Tag: Risky
Risks of Landmark Alzheimer’s Drug Prevent Australian Release
The decision not to register the Alzheimer's drug, Lecanemab, in Australia by the Therapeutic Goods Administration (TGA) has sparked discussions around the world. The...
Tag: Risky
Risks of Landmark Alzheimer’s Drug Prevent Australian Release
The decision not to register the Alzheimer's drug, Lecanemab, in Australia by the Therapeutic Goods Administration (TGA) has sparked discussions around the world. The...